Advertisement
News
Advertisement

Abiomed says no coverage decision expected for Impella

Thu, 09/27/2012 - 12:00am
Mass High Tech: The Journal of New England Technology

Danvers-based Abiomed Inc. (Nasdaq: ABMD) reported in a recent filing with the Securities and Exchange Commission that Medicare coverage of its line of Impella heart pumps will continue to be decided on a local level.

Advertisement

Share this Story

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading